Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immediate post-operative epirubicin in NMIBC
NCT02214602Phase 4Completed
- Sponsor
- Mansoura University
- Start
- Jul 2014
- Primary completion
- Apr 2017
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 4 trial of epirubicin in non-muscle-invasive bladder cancer (NMIBC), sponsored by Mansoura University. Started Jul 2014; status: completed.
02
Drugs
epirubicin
03
Conditions
non-muscle-invasive bladder cancer (NMIBC)
Beyond the preview
Go deeper on NCT02214602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02214602.